Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
6.68
-0.09 (-1.33%)
Sep 2, 2026, 2:55 PM CST
SHE:300942 Market Cap
SHE:300942 has a market cap or net worth of 2.74 billion as of September 1, 2026. Its market cap has decreased by -50.63% in one year.
Market Cap
2.74B
Enterprise Value
2.63B
Revenue
282.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.68
ChartMarket Cap Chart
Since February 9, 2021, SHE:300942's market cap has decreased from 14.45B to 2.74B, a decrease of -81.02%. That is a compound annual growth rate of -25.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 2.74B | -28.05% |
| Dec 31, 2025 | 3.81B | 10.95% |
| Dec 31, 2024 | 3.44B | -26.69% |
| Dec 29, 2023 | 4.69B | -31.80% |
| Dec 30, 2022 | 6.87B | -40.61% |
| Dec 31, 2021 | 11.57B | -19.92% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.07B |
| Beijing Kawin Technology Share-Holding | 3.01B |
| Shanghai Model Organisms Center | 2.98B |
| Zhejiang Shouxiangu Pharmaceutical | 2.93B |
| Shandong Sito Bio-technology | 2.79B |
| Hubei Goto Biopharm Group | 2.75B |
| Guangdong VTR Bio-Tech | 2.74B |
| Landfar Bio-medicine | 2.71B |